NCT04981145
The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome treatment 4 recruiting NCT04684654
BMS-986325 in Healthy Participants and Participants With Primary Sjögren's Syndrome No drug interventions treatment 1 terminated NCT02334306
A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome No drug interventions treatment 2 completed NCT01989819
Primary Sjögren Syndrome No drug interventions Not Available Not Available completed NCT02464319
A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome treatment 2 completed NCT00632866
Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome treatment 3 completed NCT03627065
A Study of INCB050465 in Primary Sjögren's Syndrome treatment 2 completed NCT02149420
PD of VAY736 in Patients With Primary Sjögren's Syndrome treatment 2 completed NCT02495129
Study of Pharmacodynamic Effects of VAY736 in Patients With Primary Sjögren's Syndrome treatment 1 / 2 withdrawn NCT02291029
Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome No drug interventions treatment 2 completed NCT06432101
Acupuncture Combined With Hydroxychloroquine No drug interventions treatment Not Available completed NCT03003572
Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity No drug interventions Not Available Not Available recruiting NCT04212572
Ultrasound Abnormalities of the Salivary Glands in Primary Sjögren's Syndrome According to the Duration of the Disease No drug interventions Not Available Not Available unknown_status NCT05817669
A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS) No drug interventions treatment 2 completed NCT01552681
Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sjögren's Syndrome treatment 2 terminated NCT06484855
Safety and Tolerability of IBI355 in Patients With Primary Sjogren's Syndrome No drug interventions treatment 1 recruiting NCT00426543
Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome treatment 2 completed NCT04858464
Reliability, Validity of the Turkish Version of the Primary Sjögren Syndrome Quality of Life (PSS-QoL) Questionnaire No drug interventions Not Available Not Available unknown_status NCT04975087
The Profile of Fatigue and Discomfort - Sicca Symptoms Inventory No drug interventions Not Available Not Available unknown_status NCT03040583
The ASSESS National Multi-center Prospective Cohort No drug interventions Not Available Not Available recruiting NCT04186871
Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis treatment 2 completed NCT04605978
Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients No drug interventions treatment 2 completed NCT02775916
Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's Syndrome treatment 2 completed NCT04078386
A Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Primary Sjögren's Syndrome No drug interventions treatment 2 completed NCT06203457
Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome No drug interventions treatment 2 active_not_recruiting NCT05087589
Efficacy, Safety and Immunological Evaluation of Tofacitinib in the Treatment of Primary Sjogren's Syndrome treatment 2 unknown_status NCT02610543
UCB Proof of Concept Study in Patients With Primary Sjögren's Syndrome treatment 2 terminated NCT06647069
DR-0201 in Subjects With Autoimmune Diseases No drug interventions treatment 1 not_yet_recruiting NCT06440525
A Study of RSLV-132 in Females with Primary Sjögren's Syndrome No drug interventions treatment 2 recruiting NCT01081184
Neurotrophins Implications in Primary Sjögren Syndrome No drug interventions Not Available Not Available completed NCT04224454
Vaccine Coverage and Primary Sjögren'Syndrome No drug interventions Not Available Not Available completed NCT03126383
Inflammatory Myopathies in Primary Sjögren's Syndrome No drug interventions Not Available Not Available unknown_status NCT03140111
LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS Patients No drug interventions treatment Not Available unknown_status NCT04816370
Effects of Primary Sjögren's Syndrome on Female Genitalia and Sexual Functions No drug interventions screening Not Available completed NCT03614299
Eye Dryness Evaluation in Primary Sjögren's Syndrome No drug interventions Not Available Not Available unknown_status NCT06519617
Study on Optimization and Evaluation of Integrated Chinese and Western Medicine for pSS Glandular Damage treatment 2 enrolling_by_invitation NCT05670535
Sjögren and Gynecologic Considerations No drug interventions Not Available Not Available completed NCT04093531
Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome treatment 1 completed NCT06049368
68Ga-P16-093 PET/CT Imaging in the Salivary Gland No drug interventions diagnostic 1 / 2 not_yet_recruiting NCT03509064
Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy No drug interventions Not Available Not Available recruiting NCT06361745
Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases No drug interventions treatment Not Available recruiting NCT04960605
Prognosis of Dental Implants in Patients With Primary Sjögren's Syndrome No drug interventions treatment Not Available completed NCT06528197
Construction of Clinical Model of Primary Sjogren's Syndrome Combined Traditional Chinese and Western Medicine No drug interventions Not Available Not Available recruiting NCT03765593
Biomarkers in Primary Sjögren's Syndrome No drug interventions Not Available Not Available unknown_status NCT03130062
Resistance Exercise in Woman With Primary Sjörgen Syndrome. No drug interventions supportive_care Not Available completed NCT04700280
A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS) No drug interventions treatment 2 terminated NCT04830644
A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome. treatment 2 unknown_status NCT03226444
Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome treatment 1 / 2 completed NCT05380804
Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome No drug interventions Not Available Not Available completed NCT03681964
Diagnostic Suspicion of Primitive Syndrome Sjögren's : Brest Cohort No drug interventions Not Available Not Available recruiting NCT05113004
New Clinical End-points in Patients With Primary Sjögren's Syndrome treatment 2 recruiting NCT01782235
Efficacy of Tocilizumab in Primary Sjögren's Syndrome. treatment 2 / 3 completed NCT05269810
Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's Syndrome treatment 2 completed NCT05673993
A Study to Evaluate the Efficacy and Safety of Telitacicept in Subjects With Active Primary Sjogren's Syndrome treatment 3 active_not_recruiting NCT05781451
Anti-BTLA Agonist Therapy in Subjects With Primary Sjogren's Syndrome treatment 2 withdrawn NCT02027298
Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study treatment 2 withdrawn NCT00542763
Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome treatment 1 completed NCT00920179
Confocal Microscopy and Lacrimal Gland in Sjogren's Syndrome No drug interventions Not Available Not Available unknown_status NCT04544722
Clinical Study of Jianfei Kangfu Cao in the Treatment of pSS-ILD No drug interventions treatment Not Available unknown_status NCT04563195
BAFF/IL-17 Bispecific Antibody Treatment in Subjects With Primary Sjogren's Syndrome treatment 2 / 3 withdrawn NCT02066896
Laser Therapy to Treat the Dry Mouth of Sjogren's Syndrome No drug interventions treatment Not Available completed NCT02004067
Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease treatment 4 completed NCT02962895
Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS) treatment 2 completed NCT01501019
Exercise in Sjogren, Myositis and Takayasu's Arteritis No drug interventions treatment Not Available unknown_status NCT00438048
A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy Treatment treatment 4 completed NCT00683345
Fatigue and Interleukin-1 (IL-1) Blockade in Primary Sjøgrens Syndrome treatment 2 completed